Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Exparel for Postsurgical Pain Relief

Annual sales of Exparel are estimated at 39 million in the US. Pacira is planning to develop partnerships to market Exparel outside the US. Image courtesy of Pacira Pharmaceuticals.



Go Top